Richmond Pharmacology
home  |  specialist services  |  TQT Studies - Thorough QT (TQT) Studies

TQT(Thorough QT) & QTc Studies

Your complete QTc/TQT/iQT Solution under one roof

Richmond Pharmacology has a globally well recognised expertise in providing consultancy on cardiac safety, the conduct of intensive ECG studies, the cardiology over-reading, statistical analysis, reporting and publishing. We can conduct "stand-alone" TQT studies or combine this with Japanese bridging and or early SAD and MAD studies.

TQT Studies


Professor Camm

bullet arrow Professor John Camm


Professor Camm's major speciality is cardiac arrhythmias but he is also much involved in clinical cardiac electrophysiology, cardiac pacemakers, risk stratification in post myocardial infarction, heart failure and cardiomyopathy drugs


View Professor Camm's profile

Dr Jorg Taubel

bullet arrow Dr Jorg Taubel


Medical practitioner and CEO of Richmond Pharmacology which he co-founded in 2001. He has worked in pharmacology for 24 years and during that time he has conducted more than 400 early phase studies in patient, paediatric and healthy volunteers.


View Dr Jorg Taubel's profile


  • Track record of 100% success in conducting QTc studies
  • Many of our QTc studies have been published. View publications »


  • State of the art methods and equipment
  • Tried and tested processing for ECG adjudication and data analysis

Cardiac safety integration in FTIM and MAD Studies

  • Excellence in ECG acquisition allows meaningful ECG analysis
  • Option to include a non-pharmacological method of proving assay sensitivity

More about our Thorough QT Studies below

  • RPL's ECG Core Lab

    Richmond Pharmacology's Core ECG Laboratory was established in 2004 to provide centralized digital and manual ECG data analysis for Richmond Pharmacology's in house TQT trials, in addition to ECG reading, analysis and reporting for clinical trials conducted at other centres.

    Learn more about RPL's ECG Core Lab
  • Why Choose RPL for TQT Studies

    Richmond Pharmacology provides their clients with FDA compliant manual over-read QT interval measurement and analysis by a team of highly trained and experienced cardiologists.
  • Our Cardio Analysis Services

    Richmond Pharmacology's Core ECG Laboratory has worked with numerous clinical units worldwide and participated in 200 clinical trials sponsored by pharmaceutical companies.

    Learn more about our Cardio Analysis Services
  • Digital ECG Analysis and Cardiologist Experience

    Thorough QT/QTc (TQT) studies are today an integral component in the development of new chemical entities (NCE) and on going drug development programmes. These studies are now so significant that they can mean the difference between the continuation and an abrupt halt of a drug development program.

    Learn more about our Digital ECG Analysis and Cardiologist Experience

TQT Studies - QTc/TQT/iQT Solutions under one roof

Benefits of using
Richmond Pharmacology

Short start-up times of 4-6 weeks; rapid data readouts

Focussed on excellent ECG generation facilitating ECG overreading

Known to regulatory agencies in EU, USA and Japan

We are fully versed about the latest requirements in cardiac safety

Low data variability allowing for the use of smaller sample sizes


Richmond Pharmacology's people have extensive knowledge and expertise.




View our latest

View Publications Publications



Learn more about Richmond
Pharmacology by viewing
some of our videos

Watch VideosVideos
© 2017 Richmond Pharmacology  |  disclaimer  |  Corporate Accounts  |  site map
Paid Clinical Trials

Thorough QT (TQT) Richmond Pharmacology is one of the leading providers of TQT studies. All TQT studies performed at Richmond Pharmacology are in collaboration with Professor Camm, Head of Cardiac and Vascular Sciences, St George's University of London, a world renowned opinion leader in cardiological analysis, providing a one stop solution unique in the field of contract research.


Richmond Pharmacology provide technical expertise for all your QTc study needs from study design, clinical conduct, ECG data management, QTc measurement and analysis, through to the final study report.


There are three essential components to any clinical study assessing the effects on the QT interval:

1) The clinical recording of ECGs

2) The measurement and verification of measurements

3) The statistical analysis of potential effects


Of these three it is essential that the clinical recording of the ECG’s are performed to the highest standard as this provides the foundation for successful completion of the other two components.


Richmond Pharmacology’s innovative approach to the conduct of TQT studies has reduced the variability rates allowing one to reduce the overall costs. In-house expertise and past experience makes Richmond Pharmacology the ideal partner for performing definitive TQT studies, all under one roof.